The impact of major depressive disorder on glycaemic control in type 2 diabetes: a longitudinal cohort study using UK Biobank primary care records
View ORCID ProfileAlexandra C Gillett, View ORCID ProfileSaskia P Hagenaars, Dale Handley, View ORCID ProfileFrancesco Casanova, View ORCID ProfileKatherine G Young, View ORCID ProfileHarry Green, View ORCID ProfileCathryn M Lewis, View ORCID ProfileJess Tyrrell
doi: https://doi.org/10.1101/2022.01.13.22269229
Alexandra C Gillett
1Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
2NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Trust, London, UK
Saskia P Hagenaars
1Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
2NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Trust, London, UK
Dale Handley
1Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
Francesco Casanova
3Clinical and Biomedical Science, Institute of Health and Life Sciences, University of Exeter, Exeter, UK
Katherine G Young
3Clinical and Biomedical Science, Institute of Health and Life Sciences, University of Exeter, Exeter, UK
Harry Green
3Clinical and Biomedical Science, Institute of Health and Life Sciences, University of Exeter, Exeter, UK
Cathryn M Lewis
1Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
2NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Trust, London, UK
4Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, King’s College London.
Jess Tyrrell
3Clinical and Biomedical Science, Institute of Health and Life Sciences, University of Exeter, Exeter, UK
Posted January 05, 2024.
The impact of major depressive disorder on glycaemic control in type 2 diabetes: a longitudinal cohort study using UK Biobank primary care records
Alexandra C Gillett, Saskia P Hagenaars, Dale Handley, Francesco Casanova, Katherine G Young, Harry Green, Cathryn M Lewis, Jess Tyrrell
medRxiv 2022.01.13.22269229; doi: https://doi.org/10.1101/2022.01.13.22269229
The impact of major depressive disorder on glycaemic control in type 2 diabetes: a longitudinal cohort study using UK Biobank primary care records
Alexandra C Gillett, Saskia P Hagenaars, Dale Handley, Francesco Casanova, Katherine G Young, Harry Green, Cathryn M Lewis, Jess Tyrrell
medRxiv 2022.01.13.22269229; doi: https://doi.org/10.1101/2022.01.13.22269229
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (712)
- Anesthesia (204)
- Cardiovascular Medicine (2965)
- Dermatology (250)
- Emergency Medicine (444)
- Epidemiology (12785)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4610)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2939)
- Health Policy (1070)
- Hematology (392)
- HIV/AIDS (927)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4392)
- Nursing (237)
- Nutrition (646)
- Oncology (2284)
- Ophthalmology (650)
- Orthopedics (259)
- Otolaryngology (327)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (501)
- Public and Global Health (6982)
- Radiology and Imaging (1539)
- Respiratory Medicine (917)
- Rheumatology (443)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)